Table 1.
Treatment groups | Evaluation periods | ||
T0 (baseline) | T1 (1-week of treatment) | T2 (1-week after treatment) | |
Control | A12.9 (±1.7)a | A12.4 (±1.3)a | A 12.5 (±0.7)a |
CP10 | A12.7 (±2.6)a | B4.4 (±2.1)b | C2.9 (±0.7)b |
CP16 | A12.7 (±1.8)a | B4.1 (±2.2)b | C2.3 (±1.3)b |
CP37 | A11.8 (±2.5)a | B7.0 (±3.2)c | C2.4 (±0.6)b |
Different capital letters indicate statistically significant differences only among the evaluation periods (p<0.001). Different lowercase letters indicate statistically significant differences only among the treatment groups (p<0.001).